Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
House Democrats releases a report highlighting potential problems in the FDA's approval of Alzheimer's drug Aduhelm.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.
3 results for "(S)-1-hydroxy-(S)-2-methylhexane"
Congress · 117th Congress
Senate’s Medicare drug pricing may ripple into private market
Congress is on the verge of allowing the government to restrict prices for drugs covered by Medicare, but experts disagree on whether drugmakers will shift costs to the private market.
Policy · 117th Congress
Democrats vow to continue fight on drug pricing in budget bill
Christopher S. Murphy, D-Conn., said his colleague Sen.